Cargando…
Efficacy and safety of growth hormone treatment for children born small for gestational age
Recombinant growth hormone (GH) is an effective treatment for short children who are born small for gestational age (SGA). Short children born SGA who fail to demonstrate catch-up growth by 2-4 years of age are candidates for GH treatment initiated to achieve catch-up growth to a normal height in ea...
Autor principal: | Hwang, Il Tae |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Pediatric Society
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4198952/ https://www.ncbi.nlm.nih.gov/pubmed/25324863 http://dx.doi.org/10.3345/kjp.2014.57.9.379 |
Ejemplares similares
-
Long-Term Efficacy and Safety of Recombinant Human Growth Hormone in
Children Born Small for Gestational Age
por: Wu, Wei, et al.
Publicado: (2023) -
Methylphenidate and the Response to Growth Hormone Treatment in Short Children Born Small for Gestational Age
por: Renes, Judith S., et al.
Publicado: (2012) -
Long-term care, from neonatal period to adulthood, of children born small for
gestational age
por: Hwang, Il Tae
Publicado: (2019) -
The Variability of Growth and Puberty in Growth Hormone-treated Children Born Small for Gestational Age
por: Saroufim, Rita, et al.
Publicado: (2022) -
The long-term safety and effectiveness of growth hormone treatment in
Japanese children with short stature born small for gestational age
por: Horikawa, Reiko, et al.
Publicado: (2020)